Cetuximab regulatory update

FDA's Oncologic Drugs Advisory Committee will meet on Dec. 16 to discuss BLAs for Erbitux cetuximab and Vectibix panitumumab in the context of K-Ras as a predictive and/or prognostic biomarker for ...